Streetbeat News

Equity Actions

VEEV

Veeva Systems has revised its FY25 revenue forecast to $2.725B-$2.740B, slightly below the previous estimate of at least $2.75B. The company also projects an adjusted EPS of $6.16, which is above the estimated $5.57. This guidance is for the fiscal year ending January 31, 2025, including non-GAAP operating income of about $1.07B.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:41 pm

NSC

Ancora Holdings Group, LLC and its affiliates (the Investor Group), holding a significant stake in Norfolk Southern Corporation (NYSE:NSC), issued an open letter criticizing the company's leadership and proposing changes. They highlighted CEO Alan Shaw's 37% pay raise despite poor performance, including the East Palestine derailment. The Investor Group nominated eight candidates for the board and proposed a new management team, urging a focus on safety, growth, and value creation. They criticized the current board's actions as serving CEO interests over shareholders and called for a fact-based election contest.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:37 pm

REE

REE Automotive has announced the pricing of its public offering, which consists of 2 million shares priced at $6.50 per share. This move is significant for investors as it provides insights into the company's current valuation and capital raising efforts.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:35 pm

NRXP

NRx Pharmaceuticals has entered into a definitive purchase agreement with an existing investor for the sale of 2.7 million shares at $0.38 per share, raising approximately $1.0 million. This represents a 26.7% premium over the recent share offering. The deal also includes a 5-year warrant with a $0.40 per share strike price. The funds will support the company's development pipeline, including projects on Suicidal Depression, Suicidal Bipolar Depression, and Chronic Pain, in addition to general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:33 pm

GDRX

GoodRx Holdings, Inc. (NASDAQ:GDRX) reported higher than expected Q4 FY23 results, with a 7% Y/Y increase in revenue to $196.6 million and adjusted EBITDA rising to $57.3 million. The company also announced a new $450 million stock repurchase program and provided FY24 revenue guidance above consensus. Following the earnings report, analysts from Barclays, JP Morgan, and TD Cowen raised their price targets on GoodRx shares, which surged 20.4% to close at $7.79.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 1:23 pm

BWAQ

Blue World Acquisition Corporation (BWAQ) has extended the deadline for its initial business combination from March 2, 2024, to April 2, 2024. To facilitate this extension, a $60,000 Extension Fee was deposited into the Company's Trust Account. This fee was funded through an unsecured promissory note issued to Blue World Holdings Limited, the sponsor of BWAQ.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:08 pm

BIVI

BioVie's Ne3107 shows promise in improving both motor and non-motor symptoms in Parkinson's disease patients and may also realign physiological processes in Alzheimer's patients. This development could significantly impact the treatment landscape for these conditions.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:05 pm

VANI

Vivani Medical has announced a registered direct offering of common stock and warrants, aiming to raise $15 million. The offering is expected to close around March 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 12:53 pm

D

Dominion Energy announced the conclusion of its business review and will host an investor meeting today to discuss its multi-year financial and capital investment guidance. This indicates a strategic move to provide transparency and potentially set the stage for future growth.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 12:44 pm

SHEN

Shenandoah Telecommunications Company (SHEN) has announced its plan to sell its towers for $310 million, with an initial closing expected in March 2024. This strategic move could potentially reshape the company's financial landscape and focus.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 12:02 pm